Apyx Medical
(NASDAQ) APYX
Apyx Medical Financials at a Glance
Market Cap
$164.15M
Revenue (TTM)
$55.90M
Net Income (TTM)
$9.17M
EPS (TTM)
$-0.22
P/E Ratio
-17.79
Dividend
$0.00
Beta (Volatility)
0.95 (Low)
Dividend
$0.00
Beta (Volatility)
0.95 (Low)
Price
$4.06
Volume
3,736
Open
$3.75
Price
$4.06
Volume
3,736
Open
$3.75
Previous Close
$4.06
Daily Range
$3.72 - $4.10
52-Week Range
$1.14 - $4.50
Dividend
$0.00
Beta (Volatility)
0.95 (Low)
Price
$4.06
Volume
3,736
Open
$3.75
Previous Close
$4.06
Daily Range
$3.72 - $4.10
52-Week Range
$1.14 - $4.50
APYX News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Apyx Medical
Industry
Healthcare Equipment and Supplies
Sector
Health CareEmployees
205
CEO
Charles D. Goodwin, II
Website
apyxmedical.comHeadquarters
Clearwater, FL 33760, US
APYX Financials
Key Financial Metrics (TTM)
Gross Margin
38%
Operating Margin
-8%
Net Income Margin
-16%
Return on Equity
-79%
Return on Capital
-8%
Return on Assets
-15%
Earnings Yield
-5.62%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$164.15M
Shares Outstanding
41.87M
Volume
3.74K
Avg. Volume
157.41K
Financials (TTM)
Gross Profit
$19.03M
Operating Income
$6.45M
EBITDA
$5.79M
Operating Cash Flow
$8.00M
Capital Expenditure
$1.11M
Free Cash Flow
$9.12M
Cash & ST Invst.
$31.74M
Total Debt
$39.34M
Apyx Medical Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$12.49M
+32.4%
Gross Profit
$7.92M
+39.9%
Gross Margin
63.45%
N/A
Market Cap
$164.15M
N/A
Market Cap/Employee
$746.12K
N/A
Employees
220
N/A
Net Income
$2.11M
+49.2%
EBITDA
$911.00K
+65.1%
Quarterly Fundamentals
Net Cash
$8.32M
-5.3%
Accounts Receivable
$12.76M
+9.5%
Inventory
$9.54M
+24.1%
Long Term Debt
$39.02M
+1.2%
Short Term Debt
$441.00K
+17.9%
Return on Assets
-14.55%
N/A
Return on Invested Capital
-8.04%
N/A
Free Cash Flow
$632.00K
+16.5%
Operating Cash Flow
$572.00K
+18.5%